Quarterly results: Sensus Healthcare (SRTS) furnishes Q3 2025 update

Rhea-AI Filing Summary

Sensus Healthcare, Inc. filed a current report to note that it issued a press release announcing its financial results for the quarter ended September 30, 2025. The company furnished this release as Exhibit 99.1 and incorporated it by reference. The press release includes certain non‑GAAP financial measures, along with reconciliations to the most directly comparable GAAP figures. The information provided under this earnings disclosure section, including Exhibit 99.1, is furnished rather than filed, which affects how it is treated under securities law.

false 0001494891 0001494891 2025-11-06 2025-11-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2025

SENSUS HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-37714		27-1647271
(State of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)
851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida				33487
(Address of principal executive offices)				(Zip Code)

Registrant’s telephone number, including area code: (561) 922-5808

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SRTS	Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

SENSUS HEALTHCARE, INC.

FORM 8-K

CURRENT REPORT

Item 2.02 Results of Operation and Financial Condition

On November 6, 2025, Sensus Healthcare, Inc. announced via press release its financial results for the quarter ended September 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The press release makes reference to certain non-GAAP financial measures. A reconciliation of the non-GAAP financial measures and other financial information is provided in the press release.

The information furnished under Item 2.02, including in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release, dated November 6, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SENSUS HEALTHCARE, INC.
Date: November 6, 2025	By:	/s/ Javier Rampolla
		Javier Rampolla
		Chief Financial Officer

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release, dated November 6, 2025.

FAQ

What did Sensus Healthcare (SRTS) disclose in this 8-K filing?

Sensus Healthcare reported that it issued a press release announcing its financial results for the quarter ended September 30, 2025, and furnished that release as Exhibit 99.1.

Which period’s results does Sensus Healthcare (SRTS) discuss in this filing?

The filing relates to Sensus Healthcare’s financial results for the quarter ended September 30, 2025.

Where can investors find Sensus Healthcare’s detailed quarterly financial results?

Detailed results are contained in the press release attached as Exhibit 99.1 to the filing, which is incorporated by reference.

Does Sensus Healthcare (SRTS) use non-GAAP measures in its quarterly results?

Yes. The press release referenced in the filing includes certain non-GAAP financial measures along with a reconciliation to comparable GAAP metrics.

Is the earnings information in this Sensus Healthcare 8-K considered filed with the SEC?

No. The information furnished under the earnings disclosure section, including Exhibit 99.1, is expressly stated as furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

Who signed the Sensus Healthcare (SRTS) 8-K related to the quarterly results?

The report was signed on behalf of Sensus Healthcare, Inc. by Javier Rampolla, the company’s Chief Financial Officer.